Mia FemTech Breast Augmentation

The Ergonomix2 Diamond implant sits at the heart of the Mia FemTech system. It has four key design features:

• Diamond shape: The implant has a symmetrical diamond form. The clinical benefit is that if any rotation occurs, the upper and lower faces are identical, so no visible asymmetry results. Rotation is one of the most common complications with anatomical (teardrop) implants; this design substantially reduces that risk.
• Low profile, soft gel: The implant uses a soft silicone gel that allows natural movement and feel within the breast tissue. The firmness associated with overfilled conventional implants is not an intended outcome here.
• SmoothSilk® nanotextured surface: The outer shell is manufactured to a surface precision of four microns. In the clinical literature, this surface type is associated with reduced bacterial adherence, lower inflammation, and lower rates of capsular contracture (see Establishment Labs prospective study results, PubMed 41052824).
• Power injection technology: Rather than the 4–5 cm incisions used for conventional silicone implants, the implant can be delivered through a much smaller incision via a specially designed injector device. This is the foundation of the system's minimal-incision approach.

The Ergonomix2 Diamond received European Union CE 2797 approval in December 2020 and is currently in active clinical use across Europe, the United Kingdom, Japan, Switzerland, Dubai, Sweden, and Spain, among other markets. FDA approval for the United States market is currently under review; the implant is not yet commercially available in the USA. In the TRNC, CE-approved medical devices are lawfully utilisable, so Mia FemTech may be performed here by certified centres.

We conduct the initial consultation by Zoom or WhatsApp video call. For the majority of our international patients, keeping the first contact online before travelling to the clinic is the most practical approach.

The assessment covers:

• Target volume increase (Mia FemTech is suited to 1–2 cup sizes — if your expectation exceeds this, the system is not appropriate)
• Breast tissue thickness and nipple position
• Chest wall anatomy, symmetry, and any asymmetry differences
• Previous surgical history (any prior breast surgery requires a dedicated assessment)
• Plans for pregnancy and breastfeeding
• Systemic health status, current medications, and allergy history

At the end of this stage, we give you a clear answer to the question: is Mia FemTech right for you? Mia FemTech is not suitable for every patient; patients seeking a large volume increase, those with very thin tissue, or those with pronounced nipple ptosis (drooping) are directed towards conventional implants or a mastopexy (breast lift).

The natural-result promise of Mia FemTech depends on the precision of the planning stage. During the consultation, we carry out a sizer (trial implant) fitting; you try sterile trial implants of different volumes inside a bra on your own body, so we can see together which volume sits well with your silhouette.

This step matters because:

• You form a realistic expectation before the operation
• Your surgeon selects the implant profile suited to your chest width
• Symmetry differences are measured in advance and incorporated into the plan
• You make your decision based on how it feels on your own body, not on an abstract image

The chosen implant size is prepared and sterilised at our clinic four days before your procedure, and arrives on the operating table in its sealed package on the day. Establishment Labs registers every Mia FemTech implant by its production number; after the operation, you receive an implant identity card and the manufacturer's warranty documentation.

The procedure begins when you arrive at the hospital in the morning, and you are discharged the same day.

Typical timeline:

• 09:00 — Admission, final examination, pre-operative marking
• 09:30 — Local anaesthetic administration and intravenous sedation preparation
• 10:00 — Creation of a supra-muscular intralaminar pocket through a small axillary incision
• Placement of the Ergonomix2 Diamond implant using the Establishment Labs power injection system
• Symmetry and position check, incision closure
• 11:00–11:30 — End of procedure, transfer to recovery room

The surgical component of the procedure typically takes 15–20 minutes (this varies with case complexity, bilateral planning, and any additional procedures). Because general anaesthesia is not required, intubation, ventilatory support, and intensive post-operative monitoring are not necessary. You remain comfortable and conscious throughout; you may listen to music if you wish.

Once the sedation has worn off and your observations are stable, you are usually discharged the same day. Transport with a companion is required.

The defining advantage of Mia FemTech is its speed of recovery. It is nonetheless a surgical procedure; patience and adherence to follow-up instructions are essential.

• First 24 hours: Mild tightness and sensitivity are normal. Prescribed simple analgesics are generally sufficient. Sleep on your back with your head slightly elevated.
• Days 2–3: You may shower. Arm movements should remain limited (avoid actions such as brushing your hair or reaching for items on high shelves).
• Days 5–7: Review appointment and suture check. The axillary scar measures approximately 5–10 mm and is largely concealed within the natural skin fold.
• Week 2: Return to desk-based work is possible for most patients. For physically demanding occupations, 3–4 weeks is recommended.
• Week 4: Light exercise (walking, Pilates) is generally permitted. Your surgeon's approval is required before returning to upper-body weight training.
• Week 6: Exercises that engage the chest and shoulder muscles may be reintroduced gradually.
• Months 3–6: Tissue settling is complete; the implant's final position and the breast's natural drape become apparent.

All review appointments take place at our clinic; for our international patients, photo-based remote follow-up is conducted via WhatsApp. In accordance with the manufacturer's protocol, the patient maintains contact with the surgical team throughout the first year; routine mammography and breast surveillance examinations are scheduled at standard intervals (in line with gynaecology and breast surgery guidelines).

• Those seeking a modest volume increase: Patients targeting a 1–2 cup size increase and wanting a natural silhouette rather than a dramatic change.
• Patients with thin tissue or an athletic build: Those at risk of implant visibility (rippling) under the skin with conventional implants, and for whom a natural feel is a priority. Supra-muscular intralaminar placement and soft gel are advantageous in this profile.
• Active lifestyles: Those who need a rapid return to work, sport, or family life and cannot accommodate a long recovery.
• Those wishing to avoid general anaesthesia: Patients who prefer local anaesthesia for reasons of anaesthetic risk, comorbidities, or personal preference.
• Those concerned about rotation with anatomical implants: Patients who have considered a teardrop implant but have reservations about rotation risk; the diamond design provides reassurance.
• Those preferring a small and concealed scar: The axillary approach leaves no visible scar on the breast — an aesthetic advantage in low-cut clothing and swimwear.
• Those who have lost breast volume after childbirth and breastfeeding: Suitable for adding a small corrective volume where skin laxity is not pronounced.

• Those seeking a large volume increase (3+ cup sizes): Mia FemTech implant volumes cannot achieve this goal. A conventional silicone implant is recommended.
• Pronounced nipple ptosis (grade 2–3): A breast lift (mastopexy) may be required first; Mia FemTech alone does not address ptosis.
• Very thin breast tissue: If tissue cover is insufficient to conceal the implant, a submuscular placement or a combined approach with fat grafting is recommended.
• Previous breast surgery: A dedicated assessment is required; capsular tissue and scar tissue may complicate Mia FemTech's supra-muscular intralaminar technique.
• Active breast disease or a suspected lesion: A general or breast surgery evaluation must come first.
• Significant systemic illness, uncontrolled diabetes, or autoimmune disease: Medical stabilisation before surgery is mandatory.
• Pregnancy or breastfeeding: No breast surgery is recommended during these periods.
• Unrealistic expectations: Patients who arrive having encountered promises of "knife-free" or "scarless" results and misunderstand these terms are given a clear picture of the actual process from the outset. Mia FemTech is a surgical procedure; it is not a non-invasive treatment.

Our responsibility in forming this assessment is clear: we will tell an unsuitable patient that the system is not right for them, and we will present all alternative options to a suitable patient. A centre that does not know how to say "this is not right for you" is, in the long term, prioritising sales over the patient.

Establishment Labs awards Mia FemTech certification on the basis of plastic surgery specialisation, advanced breast surgery experience, and completion of the company's technical training programme. Op. Dr. İbrahim Meyzin, Specialist in Plastic, Reconstructive and Aesthetic Surgery, Cyprus Turkish Medical Association Registry No: 969, is certified by Establishment Labs as the sole surgical provider of this system in the TRNC.

The practical meaning of this authorisation is as follows: the Ergonomix2 Diamond implant, the power injection device, and the surgical protocol designed by Establishment Labs are made available only to surgeons who have completed the certification process. Any claim that "Mia FemTech" is being performed at a non-certified centre is not valid under the manufacturer's protocol or regulatory framework.

Full academic background, certifications, and publication list: Doctor profile — Op. Dr. İbrahim Meyzin

Being "the only provider" carries meaning for patient safety, not for branding purposes.

• Device and implant quality is assured: Implants sourced through non-certified channels or counterfeit implants fall outside the CE/FDA registration chain. Establishment Labs' direct supply chain, implant identity card, batch number traceability, and manufacturer warranty are provided exclusively to certified centres.
• Surgical training is genuine: The incision, dissection, and implant placement techniques in Mia FemTech differ substantially from conventional breast augmentation. Certification requires hands-on training in this specific technique.
• Post-operative protocol is standardised: Follow-up intervals, complication management, and the implant registration system are aligned with the manufacturer's global standard.
• Traceability for the patient: Establishment Labs' MotivaImagine system provides the patient with a lifetime implant tracking service.

Seeking Mia FemTech at a non-certified centre in the TRNC leaves the patient exposed with regard to device authenticity, surgical safety, and manufacturer warranty. At Nis Clinic, the process is conducted in full accordance with the manufacturer's global protocol.

Mia FemTech is substantially more expensive than conventional silicone implants — this is expected. The cost difference has three layers:

1. Implant cost: The Ergonomix2 Diamond is Establishment Labs' premium implant line; its production, SmoothSilk surface technology, and certification costs exceed those of a conventional implant.
2. Power injection device: A single-use injection kit for the Mia FemTech system is sourced separately for each procedure.
3. Surgical training and technical support: Establishment Labs provides certified surgeons with ongoing training, technical support, and the MotivaImagine tracking system.

Indicative price range — Nis Clinic (Mia FemTech package): €9,000–€12,000

The conventional silicone breast augmentation package performed by the same team is in the range of €3,500–€5,500. The difference reflects the genuine cost of the system, not a marketing margin. Pricing varies according to implant volume, any concurrent procedures (such as symmetry correction), length of stay, and additional services. A confirmed figure is provided after consultation.

Package inclusions: airport transfers, 2–3 nights' accommodation, surgery, implant and single-use injection kit, local anaesthesia and sedation, medications, post-operative bra, first-year review appointments, MotivaImagine implant registration system, 24/7 WhatsApp support. No hidden fees.

Related pages: Medical tourism packages and conventional breast augmentation alternative.